PO.ET02.01 · 实验与分子治疗

基于板的偶联技术用于ADC开发中的抗体与载荷优化

Plate-based conjugation for antibody and payload optimization in ADC development

海报缩略图:基于板的偶联技术用于ADC开发中的抗体与载荷优化
编号 1679 展板 8 时间 4/20 09:00–12:00 区域 Section 12 主讲 Julien Dugal-Tessier, PhD
分会场 Antibody-Drug Conjugates and Linker Engineering 1
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Zeinab Fereshteh, Madhavi Latha S. Chalasani, Rupa Sarkar, Julien Dugal-Tessier, Nareshkumar Jain

NJ Bio, Inc., Princeton, NJ

摘要 Abstract

中文摘要
ADC通常是逐个合成的,不适合使用平台化方法进行早期筛选。我们开发了一个基于板的偶联平台,利用基于马来酰亚胺的连接子-载荷,将早期筛选与体外表征相整合。凭借标准化、可与检测兼容的方案,该高通量系统能够快速评估DAR、纯度、产率、细胞毒性和结合能力。它支持采用固定连接子-载荷进行抗体筛选、采用固定抗体进行载荷筛选,以及在不同条件下进行ADC表征,为合理化ADC设计提供了强大的工具。
查看英文原文 English abstract
ADCs are typically synthesized one by one and not amenable to early screening using a platform method. We developed a plate-based conjugation platform that integrates early screening with in vitro characterization using maleimide-based linker-payloads. With a standardized, assay-compatible protocol, this high-throughput system rapidly assesses DAR, purity, yield, cytotoxicity, and binding. It supports antibody screening with fixed linker-payloads, payload screening with fixed antibodies, and ADC characterization under varied conditions, providing a powerful tool for rational ADC design.
利益披露 Disclosure
Z. Fereshteh, None.. M. S. Chalasani, None.. R. Sarkar, None.. J. Dugal-Tessier, None.. N. Jain, None.

← 返回 AACR 2026 检索